Cellular senescence can be triggered by a variety of signals, including loss of telomeric integrity or intense oncogenic signaling, and is considered a potent, natural tumor suppressor mechanism. Previously, it was shown that the promyelocytic leukemia protein (PML) induces cellular senescence when overexpressed in primary human fibroblasts. The mechanism by which the PML IV isoform elicits this irreversible growth arrest is believed to involve activation of the tumor suppressor pathways p21/p53 and p16/Rb; however, a requirement for either pathway has not been demonstrated unequivocally. To investigate the individual contributions of p53 and Rb to PML-induced senescence, we used oncoproteins E6 and E7 from human papillomaviruses (HPVs), which predominantly target p53 and Rb. We show that E7, but not E6, circumvents PML-induced senescence. Using different E7 mutant proteins, dominant negative cyclin-dependent kinase 4, and p16 RNA interference, we demonstrate that Rb-related and Rb-independent mechanisms of E7 are necessary for subversion of PML-induced senescence and we identify PML as a novel target for E7. Interaction between E7 and a functional prosenescence complex composed of PML, p53, and CBP perturbs transcriptional activation of p53, thus highlighting a significant effect also on the p53 tumor suppressor pathway. Given the importance of HPV in the pathogenesis of cervical cancer, our results warrant a more detailed analyses of PML in HPV infections.
Cellular senescence was first recognized by Hayflick andMoorhead (26) as a mechanism that limits the life span of primary human fibroblasts in culture. We now know that this mechanism, referred to as replicative senescence, is linked to the integrity of telomeres (51). Stimuli that do not affect telomeric integrity were also shown to lead to a permanent cell cycle arrest showing features of cellular senescence (49). These stimuli irreversibly arrest growth after only a few cell divisions, and the phenomenon therefore is referred to as premature senescence. Stimuli leading to premature senescence include DNA damage (55) and intense mitogenic signaling, as, for example, by oncogenic Ras, Raf1, or MEK (35,50,63).The commonality among factors inducing premature senescence is that all have the potential to cause or contribute to cancer. Thus, cellular senescence appears to be a mechanism for irreversibly arresting the growth of cells at risk for tumorigenesis (9). The most compelling link between cellular senescence and tumor suppression is their mutual dependence on tumor suppressor genes such as these p16, p21, p53, and Rb genes (8).Recent results indicate that another candidate tumor suppressor, promyelocytic leukemia protein (PML), is involved in controlling cellular senescence (5, 22, 41). The PML gene was initially identified in patients with acute promyelocytic leukemia, in whom it is fused to the retinoic acid receptor ␣ gene as a result of the t(15;17) chromosomal translocation. The expression of the PML-retinoic acid receptor ␣ fusion protein is suffici...